Tecan Group Ltd (TECN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Tecan Group Ltd (TECN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7193
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan’s products find applications in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions and synthetic biology. The company has manufacturing facilities, and research and development facilities in Europe and North America. Tecan is headquartered in Mannedorf, Zurich, Switzerland.

Tecan Group Ltd (TECN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Tecan Group Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 10
IBL International And Leiden University Medical Centre Enter Into Licensing Agreement For Myasthenia Gravis Diagnostics 11
Radisens Enters Into Licensing Agreement With Tecan 12
DiaSorin Enters into Agreement with Tecan 13
Singulex Enters Into Co-Development Agreement With Tecan 14
ViroGates Enters Into Distribution Agreement With IBL International 15
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 16
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 17
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 18
Reinnervate Enters Into Co-Development Agreement With Tecan Group 19
University of Duisburg-Essen Enters Into Licensing Agreement With IBL International 20
Acquisition 21
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 21
Tecan Acquires SPEware 22
Tecan Completes Acquisition of IBL International for USD39 Million 23
Tecan Group Ltd – Key Competitors 24
Tecan Group Ltd – Key Employees 25
Tecan Group Ltd – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Aug 16, 2018: H1 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business 28
Aug 16, 2018: Tecan: Financial results for the first half of 2018 31
Aug 16, 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business 34
Aug 16, 2017: H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business 37
Mar 15, 2017: Full year 2016: Another year of double-digit sales growth for Tecan 40
Corporate Communications 43
Oct 06, 2017: Tecan initiates succession process for the Board of Directors 43
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development 44
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development 45
Jan 10, 2017: Tecan appoints Klaus Lun Head of the Life Sciences Business division 46
Other Significant Developments 47
Jul 03, 2018: Tecan’s Spark reader aiding research into rare skin disease 47
Jan 25, 2018: Tecan to launch Fluent Gx Automation Workstation for use in regulated laboratories 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Tecan Group Ltd, Medical Equipment, Key Facts, 2017 2
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Deals By Market, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 10
IBL International And Leiden University Medical Centre Enter Into Licensing Agreement For Myasthenia Gravis Diagnostics 11
Radisens Enters Into Licensing Agreement With Tecan 12
DiaSorin Enters into Agreement with Tecan 13
Singulex Enters Into Co-Development Agreement With Tecan 14
ViroGates Enters Into Distribution Agreement With IBL International 15
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 16
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 17
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 18
Reinnervate Enters Into Co-Development Agreement With Tecan Group 19
University of Duisburg-Essen Enters Into Licensing Agreement With IBL International 20
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 21
Tecan Acquires SPEware 22
Tecan Completes Acquisition of IBL International for USD39 Million 23
Tecan Group Ltd, Key Competitors 24
Tecan Group Ltd, Key Employees 25
Tecan Group Ltd, Subsidiaries 26

List of Figures
Tecan Group Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Tecan Group Ltd (TECN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Yara International ASA:企業の戦略・SWOT・財務分析
    Yara International ASA - Strategy, SWOT and Corporate Finance Report Summary Yara International ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Volkswagen Financial Services AG:戦略・SWOT・企業財務分析
    Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report Summary Volkswagen Financial Services AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Digital China Holdings Limited:企業の戦略・SWOT・財務情報
    Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Digital China Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The Manufacturers Life Insurance Co:電力:M&Aディール及び事業提携情報
    Summary The Manufacturers Life Insurance Company (Manufacturers Life Insurance) is a financial service provider, based in Canada. The company provides financial protection, and wealth management products and services, and also asset management services to institutional customers. It offers individua …
  • Abu Dhabi National Oil Co-石油・ガス分野:企業M&A・提携分析
    Summary Abu Dhabi National Oil Company (ADNOC) is a vertically integrated national oil and gas group. The group is active in exploration and production, support services, oil refining and gas processing, chemicals and petrochemicals, maritime transportation and refined products and distribution. ADN …
  • Monsoon Accessorize Ltd:企業の戦略・SWOT・財務分析
    Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report Summary Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Rosehill Resources Inc (ROSE):企業の財務・戦略的SWOT分析
    Rosehill Resources Inc (ROSE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ImpediMed Ltd (IPD):企業の財務・戦略的SWOT分析
    ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Lietuvos energijos gamyba, AB (LNR1L):電力:M&Aディール及び事業提携情報
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Solaris Oilfield Infrastructure Inc (SOI):石油・ガス:M&Aディール及び事業提携情報
    Summary Solaris Oilfield Infrastructure Inc (Solaris) is a provider of supply chain management and logistics solutions for oil and natural gas industry. The company manufactures and provides mobile proppant management systems that unload, store and deliver proppant at oil and natural gas well sites …
  • SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析
    Summary SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. …
  • Kirloskar Brothers Ltd (KIRLOSBROS):企業の財務・戦略的SWOT分析
    Kirloskar Brothers Ltd (KIRLOSBROS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cryostar SAS:企業の戦略的SWOT分析
    Cryostar SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Euro Disney S.C.A.:戦略・SWOT・企業財務分析
    Euro Disney S.C.A. - Strategy, SWOT and Corporate Finance Report Summary Euro Disney S.C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • New World Development Company Limited:企業の戦略・SWOT・財務分析
    New World Development Company Limited - Strategy, SWOT and Corporate Finance Report Summary New World Development Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • BioDot Inc-医療機器分野:企業M&A・提携分析
    Summary BioDot Inc (BioDot) is a healthcare products provider that manufactures low volumes of fluids and powder dispensing products. The company offers lateral flow, immunoblots, biojet, airjet, dry chemistry, bio chips, low volume PCR, glucose biosensors, biosensors, polyject and dispo powder disp …
  • SSA Marine, Inc.:企業の戦略・SWOT・財務分析
    SSA Marine, Inc. - Strategy, SWOT and Corporate Finance Report Summary SSA Marine, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vallourec SA:企業の戦略・SWOT・財務情報
    Vallourec SA - Strategy, SWOT and Corporate Finance Report Summary Vallourec SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Eiger BioPharmaceuticals Inc (EIGR):企業の財務・戦略的SWOT分析
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • QuadraMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Quadramed Corporation (Quadramed), is a N. Harris Computer Corp., is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamli …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆